NPCE - NeuroPace Inc
IEX Last Trade
7.92
-0.030 -0.379%
Share volume: 35,623
Last Updated: Fri 30 Aug 2024 09:59:48 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$7.95
-0.03
-0.38%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-08 | 2023-03-02 | 2023-05-04 | 2023-08-08 | 2023-11-06 | 2024-03-05 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 118.544 M | 120.474 M | 114.106 M | 106.271 M | 102.232 M | 99.300 M | 107.651 M | 98.853 M | |
| Current Assets | 112.464 M | 104.370 M | 97.714 M | 90.156 M | 86.511 M | 83.974 M | 92.719 M | 84.254 M | |
| Inventories | 8.419 M | 8.581 M | 9.712 M | 10.750 M | 10.014 M | 9.759 M | 11.214 M | 11.416 M | |
| Other Current Assets | 3.160 M | 2.501 M | 3.111 M | 2.597 M | 2.050 M | 1.588 M | 2.737 M | 2.262 M | |
| Short Term Investments | 3.160 M | 2.501 M | 3.111 M | 2.597 M | 2.050 M | 1.588 M | 2.737 M | 2.262 M | |
| Total Receivables | 8.474 M | 7.876 M | 7.482 M | 9.194 M | 10.876 M | 11.279 M | 12.314 M | 11.631 M | |
| Current Cash | 92.411 M | 85.412 M | 77.409 M | 67.615 M | 63.571 M | 61.348 M | 66.454 M | 58.945 M | |
| Total Non-current Assets | 6.080 M | 16.104 M | 16.392 M | 16.115 M | 15.721 M | 15.326 M | 14.932 M | 14.599 M | |
| Property Plant Equipment | 951.000 K | 894.000 K | 1.064 M | 1.024 M | 976.000 K | 949.000 K | 1.003 M | 1.048 M | |
| Other Assets | 5.007 M | 15.088 M | 15.206 M | 14.969 M | 14.623 M | 14.255 M | 13.807 M | 13.429 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 118.544 M | 120.474 M | 114.106 M | 106.271 M | 102.232 M | 99.300 M | 107.651 M | 98.853 M | |
| Total liabilities | 65.642 M | 77.065 M | 79.329 M | 78.781 M | 81.006 M | 82.937 M | 86.997 M | 84.512 M | |
| Total current liabilities | 11.401 M | 9.417 M | 10.976 M | 9.875 M | 11.508 M | 12.815 M | 16.229 M | 13.110 M | |
| Accounts Payable | 1.503 M | 1.175 M | 2.147 M | 1.829 M | 1.807 M | 1.207 M | 2.332 M | 3.268 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 2.936 M | 692.000 K | 1.415 M | 1.466 M | 1.519 M | 1.572 M | 1.627 M | 1.683 M | |
| Long term debt | 54.241 M | 67.648 M | 68.353 M | 68.906 M | 69.498 M | 70.122 M | 70.768 M | 71.402 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 52.902 M | 43.409 M | 34.777 M | 27.490 M | 21.226 M | 16.363 M | 20.654 M | 14.341 M | |
| Common stock | 24.504 M | 24.729 M | 24.839 M | 25.097 M | 25.473 M | 26.017 M | 26.820 M | 28.285 M | |
| Retained earnings | -447.922 M | -459.707 M | -470.853 M | -481.228 M | -490.352 M | -497.609 M | -503.809 M | -512.734 M |